The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia
新型酪氨酸激酶抑制剂AKN-028在急性髓系白血病细胞系和原代培养物中具有显著的抗白血病活性。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2012.28
Eriksson, A; Hermanson, M; Wickström, M; Lindhagen, E; Ekholm, C; Jenmalm Jensen, A; Löthgren, A; Lehmann, F; Larsson, R; Parrow, V; Höglund, M